Experimental models and methods in antibody targeting of renal cell carcinoma

Methods in Molecular Medicine

Volumn 53, Issue , 2015, Pages 217-242

  Vessella, Robert L ^a   Wilbur, D Scott ^a   Buhler, Kent ^a   Lange, Paul H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY CONJUGATE; ASTATINE 211; BIOTIN; BIOTIN DERIVATIVE; BISMUTH 213; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN F(AB) FRAGMENT; IODINE 131; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY A6H; STANNYLBENZOATE BIOTIN; STREPTAVIDIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ASCITES; DRUG TARGETING; EXPERIMENTAL DESIGN; EXPERIMENTAL MODEL; IN VITRO STUDY; ISOTOPE LABELING; KIDNEY CARCINOMA; MALE; METASTASIS; MOUSE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN PROCESSING; PROTEIN PURIFICATION; RADIOIMMUNOASSAY; RADIOIMMUNOTHERAPY; RADIOIODINATION; RADIOISOTOPE DISTRIBUTION; RADIOISOTOPE THERAPY; SUCCINYLATION; TISSUE DISTRIBUTION; TUMOR LOCALIZATION; TUMOR XENOGRAFT;

EID: 84869023295     PISSN: 15431894     EISSN: 19406037     Source Type: Book Series    
DOI: None     Document Type: Article

References (34)

1. Mulders, P., Figlin, R., DeKernion, J. B., Wiltrout, R., Linehan, M., Parkinson, D., DeWolf, W., and Belldegrun, A. (1997) Renal cell carcinoma: recent progress and future directions. Cancer Res. 57, 5189–5195.
2. DeKernion, J. B. (1997) Renal tumors, in Campbell’s Urology (Walsh, P. C., Gittes, R. F., Perlmutter, A. D., et al., eds.), Saunders Press, Philadelphia, pp. 1294–1342.
3. Wilbur, D. S., Hamlin, D. K., Vessella, R. L., Stray, J. E., Buhler, K. R., Stayton, P. S., Klumb, L. A., Pathare, P. M., and Weerawarna, S. A. (1996) Antibody fragments in tumor pretargeting. Evaluation of biotinylated fab’ colocalization with recombinant streptavidin and avidin. Bioconjug.Chem. 7, 689–702.
4. Wilbur, D. S., Hamlin, D. K., Buhler, K. R., Pathare, P. M., Vessella, R. L., Stayton, P. S., and To, R. (1998) Streptavidin in antibody pretargeting. 2. Evaluation of methods for decreasing localization of streptavidin to kidney while retaining its tumor binding capacity. Bioconjug. Chem. 9, 322–330.
5. Wilbur, D. S., Hamlin, D. K., Pathare, P. M., and Weerawarna, S. A. (1997) Biotin reagents for antibody pretargeting. Synthesis, radioiodination, and in vitro evaluation of water soluble, biotinidase resistant biotin derivatives. Bioconjug. Chem. 8, 572–584.
6. Hymes, J., Fleischhauer, K., and Wolf, B. (1997) Biotinidase in serum and tissues. Methods Enzymol. 279, 422–434.
7. Chiou, R. K., Vessella, R. L., Elson, M. K., Clayman, R. V., Gonzalez-Campoy, J., Klicka, M. J., Shafer, R. B., and Lange, P. H. (1985) Localization of human renal cell carcinoma xenografts with a tumor-preferential monoclonal antibody. Cancer Res. 45, 6140–6146.
8. Vessella, R. L., Alvarez, V., Chiou, R. K., Rodwell, J., Elson, M. K., Palme, D. F., Shafer, R. B., and Lange, P. H. (1987) Radioimmunoscintingraphy and radioimmunotherapy of renal cell carcinoma xenografts. Natl. Cancer Inst. Monogr. 3, 159–167.
9. Vessella, R. L., Lange, P. H., Palme, D. F., Chiou, R. K., Elson, M. K., and Wessels, B. W. (1988) Radioiodinated monoclonal antibodies in the imaging and treatment of human renal cell carcinoma xenografts in nude mice. Targeted Diagn. Ther. 1, 245–282.
10. Vessella, R. L., Moon, T. D., Chiou, R. K., Nowak, J. A., Arfman, E. W., Palme, D. F., Peterson, G. A., and Lange, P. H. (1985) Monoclonal antibodies to human renal cell carcinoma: recognition of shared and restricted tissue antigens. Cancer Res. 45, 6131–6139.
11. Wessels, B. W., Vessella, R. L., Palme, D. F., Berkopec, J. M., Smith, G. K., and Bradley, E. W. (1989) Radiobiological comparison of external beam irradiation and radioimmunotherapy in renal cell carcinoma xenografts. Int. J. Radiat. Oncol. Biol. Phys. 17, 1257–1263.
12. Palme, D. F., Berkopec, J. M., Elson, M. K., Wessels, B. W., Lange, P. H., and Vessella, R. L. (1991) Dosimetry and pharmacokinetics of monoclonal antibody A6H with human renal cell carcinoma xenografts: single dose study. Int. J. Rad. Appl. Instrum. [B] 18, 527–537.
13. Vessella, R. L. (1991) Radioimmunoconjugates in renal cell carcinoma, in Immunotherapy of Renal Cell Carcinoma (Debruyne, F. M. J., Bukowski, R. M., Pontes, J. E., and de Mulder, P. H. M., eds.), Springer-Verlag, Heidelberg, pp. 38–46.
14. Bloomer, W. D., McLaughlin, W. H., Adelstein, S. J., and Wolf, A. P. (1984) Therapeutic applications of auger and alpha emitting radionuclides. Strahlentherapie 160, 755–757.
15. Macklis, R. M., Kinsey, B. M., Kassis, A. I., Ferrara, J. L. M., Atcher, R. W., Hines, J. J., Coleman, C. N., Adelstein, S. J., and Burakoff, S. J. (1988) Radioimmunotherapy with alpha-particle-emitting immunoconjugates. Science 240, 1024–1026.
16. Wilbur, D. S. (1991) Potential use of alpha emitting radionuclides in the treatment of cancer. Antibody Immunoconjug. Radiopharm. 4, 85–97.
17. Zalutsky, M. R. and Bigner, D. D. Radioimmunotherapy with a-particle emitting radioimmunoconjugates. Acta Oncol. 35, 373–379.
18. Feinendegen, L. E. and McCombie, R. (1997) Alphapemiters for medical therapy—workshop of the United States Department of Energy. Radiat. Res. 148, 195–201.
19. Visser, G. W. M., Diemer, E. L., and Kaspersen, F. M. (1981) The nature of the astatine-protein bond. Int. J. Appl. Rad. Isot. 32, 905–912.
20. Wilbur, D. S., Hylarides, M. D., and Fritzberg, A. R. (1989) Reactions of Organometallic Compounds with Astatine-211. Application of protein labeling. Radiochim. Acta 47, 137–142.
21. Zalutsky, M. R. and Narula, A. S. (1988) Astatination of proteins using an Nsuccinimidyl Tri-n-butylastannyl benzoate intermediate. Appl. Radiat. Isot. 39, 227–232.
22. Wilbur, D. S., Hadley, S. W., Hylarides, M. D., Abrams, P. G., Beaumier, P. A., Morgan, A. C., Reno, J. M., and Fritzberg, A. R. (1989) Development of a Stable Radioiodinating Reagent to Label Monoclonal Antibodies for Radiotherapy of Cancer. J. Nucl. Med. 30, 216–226.
23. 2. Int. J. Radiat. Appl. Instrum. [B] 20, 917–927.
24. 125I]iodophenethyl) maleimide-antibody conjugate. Bioconjug. Chem. 2, 435–440.
25. 125I]iodobenzoyl conjugate. Bioconjug. Chem. 2, 171–179.
26. Hnatowich, D. J., Virzi, F., and Rusckowski, M. (1987) Investigations of avidin and biotin for imaging applications. J. Nucl. Med. 28, 1294–1302.
27. Paganelli, G., Pervez, S., Siccardi, A. G., Rowlinson, G., Deleide, G., Chiolerio, F., Malcovati, M., Scassellati, G. A., and Epenetos, A. A. (1990) Intraperitoneal radio-localization of tumors pre-targeted by biotinylated monoclonal antibodies. Int. J. Cancer 45, 1184–1189.
28. Paganelli, G., Malcovati, M., and Fazio, F. (1991) Monoclonal antibody pretargetting techniques for tumour localization; the avidin-biotin system. International workshop on techniques for the avidin-biotin system. International Workshop on Techniques for Amplification of Tumour Targetting. Nucl. Med. Commun. 9, 211–234.
29. Wilbur, D. S., Stayton, P. S., To, R., Buhler, K. R., Klumb, L. A., Hamlin, D. K., Stray, J. E., and Vessella, R. L. (1998) Streptavidin in antibody pretargeting. Comparison of a recombinant streptavidin with two streptavidin mutant proteins and two commercially available streptavidin proteins. Bioconjug. Chem. 9, 100–107.
30. Wilbur, D. S., Pathare, P. M., Hamlin, D. K., Stayton, P. S., To, R., Klumb, L. A., Buhler, K. R., and Vessella, R. L. (1999) Development of new biotin/streptavidin regents for pretargeting. Biomol. Eng. 16, 113–118.
31. Hymes, J. and Wolf, B. (1996) Biotinidase and its roles in biotin metabolism. Clin. Chim. Acta 255, 1–11.
32. Pispa, J. (1965) Animal biotinidase. Ann. Med. Exp. Biol. Fenn. (Suppl. 5)43, 1–39.
33. Wilbur, D. S., Pathare, P. M., Hamlin, D. K., Buhler, K. R., and Vessella, R. L. (1998) Biotin reagents for antibody pretargeting. 3. Synthesis, radioiodination, and evaluation of biotinylated starburst dendrimers. Bioconjug. Chem. 9, 813–825.
34. Pathare, P. M., Hamlin, D. K., Wilbur, D. S., Brechbiel, M. W., and Bray, L. A. (1998) Synthesis and radiolabeling of a biotin-CHX-B chelate for Bi-213. J. Labelled Comput. Radiopharm. 41, 595–603.